麻豆AV

Dr. Ducharme is a Neuropsychiatrist with a board certification in Behavioral Neurology & Neuropsychiatry from the United College of Neurological Subspecialities. He received his medical degree from the Universit茅 de Montr茅al in 2007, followed by a residency in Psychiatry at 麻豆AV and a Neuropsychiatry fellowship at Harvard University. His clinical practice at the 麻豆AV Health Centre (MUHC) and Montreal Neurological Institute (MNI) focuses on dementia with behavioral components, most notably frontotemporal dementia (FTD). He also evaluates and treat patients with neuropsychiatric complications of epilepsy, chronic traumatic brain injuries, and psychogenic non-epileptic seizures.

Dr. Ducharme is an FRQS-funded faculty of the MNI McConnell Brain Imaging Centre. His research uses advanced structural brain imaging techniques to study the longitudinal changes in brain development from childhood to old age, and how it impacts behavior across health and psychopathology. His current projects aim to develop novel neuroimaging diagnostic and prognostic biomarkers for FTD. He is the co-leader of the FTD team of the Canadian Consortium for Neurodegeneration in Aging and the Montreal PI of the Genetic Frontotemporal Dementia Initiative study. He is also in charge of several innovative clinical trials on dementia at the Neuro. Dr. Ducharme has received multiple awards including the Career Development Award from American Neuropsychiatric Association in 2013. He is the research director of the MUHC mental health mission, the Director of the Committee on Research of the American Neuropsychiatric Association and the Director of the 麻豆AV Geriatric Psychiatry & Neuropsychiatry Division.